Patents by Inventor Jean Man Kim

Jean Man Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9200062
    Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: December 1, 2015
    Assignee: GREEN CROSS CORPORATION
    Inventors: Se-Ho Kim, Ki Hwan Chang, Kwang-Won Hong, Yong-Won Shin, Min-soo Kim, Hae-Won Lee, Kyung Hwan Ryoo, Dong Hyuck Seo, Jean Man Kim, Yong Nam Shin, Sunmi Koo, Jung-Ae Lim, Mijung Lee, Yeon Kyung Lee, Misun Seo
  • Publication number: 20140302598
    Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.
    Type: Application
    Filed: May 21, 2014
    Publication date: October 9, 2014
    Inventors: Se-Ho KIM, Ki Hwan CHANG, Kwang-Won HONG, Yong-Won SHIN, Min-soo KIM, Hae-Won LEE, Kyung Hwan RYOO, Dong Hyuck SEO, Jean Man KIM, Yong Nam SHIN, Sunmi KOO, Jung-Ae LIM, Mijung LEE, Yeon Kyung LEE, Misun SEO
  • Patent number: 8840895
    Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: September 23, 2014
    Assignee: Green Cross Corporation
    Inventors: Se-Ho Kim, Ki Hwan Chang, Kwang-Won Hong, Yong-Won Shin, Min-soo Kim, Hae-Won Lee, Kyung Hwan Ryoo, Dong Hyuck Seo, Jean Man Kim, Yong Nam Shin, Sunmi Koo, Jung-Ae Lim, Mijung Lee, Yeon Kyung Lee, Misun Seo
  • Publication number: 20120264921
    Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.
    Type: Application
    Filed: July 8, 2010
    Publication date: October 18, 2012
    Applicant: GREEN CROSS CORPORATION
    Inventors: Se-Ho Kim, Ki Hwan Chang, Kwang-Won Hong, Yong-Won Shin, Min-soo Kim, Hae-Won Lee, Kyung Hwan Ryoo, Dong Hyuck Seo, Jean Man Kim, Yong Nam Shin, Sunmi Koo, Jung-Ae Lim, Mijung Lee, Yeon Kyung Lee, Misun Seo
  • Patent number: 6887852
    Abstract: Disclosed is a lyophilized preparation of recombinant factor VIII used as a therapeutic preparation of hemophilia A. The lyophilized preparation of recombinant factor VIII is prepared by performing lyophilization using a mixture comprising 6 to 100 mM of L-arginine, 3.5 to 50 mM of L-isoleucine, and 10 to 100 mM of L-glutamic acid as a stabilizer for stabilizing the recombinant factor VIII which exhibits an unstable activity during lyophilization, rather than using human blood derived albumin.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: May 3, 2005
    Assignee: Korea Green Cross Corporation
    Inventors: Sang Hoon Paik, Yong Nam Shin, Jean Man Kim, Jae Wook Huh, Jung Sik Lee, Ki Sung Kwon, Ji Hyun Chun